Fatores prognósticos no Linfoma de Hodgkin pediátrico no estado do Paraná - Brasil

Abstract

While the 5 year global survival rates for Hodgkin Lymphoma patients are beyond 93%, the toxicity of the treatment is a major problem. We performed a study that aims to identify prognostic factors at diagnosis that could suggest more or less aggressive treatment protocols. In this population, the 5 years overall survival rate was 93,8%, while the 5 years event-free survival was 86,7%. Advanced stages, involvement of more than one site at diagnosis, extranodal disease and the delay on sending the patient for the specialist were identified as prognostic factors.